Erasca Stock 715%. Here’s Why One Biotech Fund Still Bets More
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Learn which indices traders watch most closely and why. This quick primer covers the benchmarks that shape trading strategies and risk assessment.
26,463 articlesA major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
Two very different paths define the nuclear renaissance: NuScale's small modular reactors and BWX Technologies' broad...
Malin Akerman and husband Jack Donnelly have put their Hollywood Hills retreat on the market for around $3 million. T...
Navitas Semiconductor is making headlines as its stock climbs. This piece breaks down why navitas semiconductor stock...
Dive into Lakeland’s 2027 earnings narrative. Learn the drivers, margins, risks, and how to assess the stock for long...
A hidden Medicare surcharge tied to income can lift monthly costs by hundreds for pre-retirees. Here’s how IRMAA work...
A mid-year departure of a physician from a Medicare Advantage network can trap beneficiaries until the January enroll...
U.S. regulators have cleared broader access to Anthropic’s Mythos model after a brief regulatory stand-off over safet...
Lawmakers edge toward final action on the ROAD Act, a bill that could reshape how lenders price risk and how quickly ...
The SEC is signaling a shift in how ETFs operate, potentially opening doors for crypto investments. This guide explai...
A rare public reversal from Elon Musk shines a light on Anthropic as a leading AI player. For Amazon and Alphabet inv...
Kratos Defense stock just moved lower after a compelling earnings beat, leaving investors wondering what comes next. ...